Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
- PMID: 17981738
- DOI: 10.2741/2870
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
Abstract
Over the last decade, adenosine receptors in the central nervous system have been implicated in the modulation of cognitive functions. Despite the general view that endogenous adenosine modulates cognition through the activation of adenosine A1 receptors, evidence is now emerging on a possible role of A2A receptors in learning and memory. The present review attempts to examine results reported in different studies using diverse animal models, to provide a comprehensive picture of the recent evidence of a relationship between adenosinergic function and memory deficits. The present data suggest that caffeine (a nonselective adenosine receptor antagonist) and selective adenosine A2A receptor antagonists can improve memory performance in rodents evaluated through different tasks. They might also afford protection against memory dysfunction elicited in experimental models of aging, Alzheimer's disease, Parkinson's disease and, in spontaneously hypertensive rats (SHR), a putative genetic model of attention deficit hyperactivity disorder (ADHD).
Similar articles
-
Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: a rodent model of attention-deficit hyperactivity disorder.Behav Pharmacol. 2009 Mar;20(2):134-45. doi: 10.1097/FBP.0b013e32832a80bf. Behav Pharmacol. 2009. PMID: 19307960
-
Adenosine receptor control of cognition in normal and disease.Int Rev Neurobiol. 2014;119:257-307. doi: 10.1016/B978-0-12-801022-8.00012-X. Int Rev Neurobiol. 2014. PMID: 25175970 Review.
-
Caffeine improves spatial learning deficits in an animal model of attention deficit hyperactivity disorder (ADHD) -- the spontaneously hypertensive rat (SHR).Int J Neuropsychopharmacol. 2005 Dec;8(4):583-94. doi: 10.1017/S1461145705005341. Epub 2005 May 9. Int J Neuropsychopharmacol. 2005. PMID: 15877934
-
Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorder.Eur Neuropsychopharmacol. 2013 Apr;23(4):317-28. doi: 10.1016/j.euroneuro.2012.04.011. Epub 2012 May 4. Eur Neuropsychopharmacol. 2013. PMID: 22561003
-
Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline.J Alzheimers Dis. 2010;20 Suppl 1:S95-116. doi: 10.3233/JAD-2010-1408. J Alzheimers Dis. 2010. PMID: 20182043 Review.
Cited by
-
Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks.Molecules. 2016 Jul 27;21(8):974. doi: 10.3390/molecules21080974. Molecules. 2016. PMID: 27472311 Free PMC article. Review.
-
Adenosine A2A receptor deficiency alleviates blast-induced cognitive dysfunction.J Cereb Blood Flow Metab. 2013 Nov;33(11):1789-98. doi: 10.1038/jcbfm.2013.127. Epub 2013 Aug 7. J Cereb Blood Flow Metab. 2013. PMID: 23921902 Free PMC article.
-
Differential Behavioral and Biochemical Responses to Caffeine in Male and Female Rats from a Validated Model of Attention Deficit and Hyperactivity Disorder.Mol Neurobiol. 2018 Nov;55(11):8486-8498. doi: 10.1007/s12035-018-1000-5. Epub 2018 Mar 20. Mol Neurobiol. 2018. PMID: 29557061
-
Emerging Nondopaminergic Medications for Parkinson's Disease: Focusing on A2A Receptor Antagonists and GLP1 Receptor Agonists.J Mov Disord. 2021 Sep;14(3):193-203. doi: 10.14802/jmd.21035. Epub 2021 Aug 18. J Mov Disord. 2021. PMID: 34399565 Free PMC article.
-
Therapeutics of Neurotransmitters in Alzheimer's Disease.J Alzheimers Dis. 2017;57(4):1049-1069. doi: 10.3233/JAD-161118. J Alzheimers Dis. 2017. PMID: 28211810 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical